Abstract:Developing biocompatible, multifunctional and in-situ labeling nanoplatform is high challenging for molecular imaging. Organic derivates melanin nanoparticles (MNPs) holds great potential to be multimodal contrast agents, and have been used for photoacoustic imaging, magnetic resonance imaging, and Cu-64 PET imaging with simple modifications. In order to extend MNPs application in molecular imaging, here a novel radio-nuclide was applied to in-situ labeling of MNPs. Large numbers of active dihydroxyindole/indolequinone groups and natural binding ability of MNPs enabled them to have the ability to label different types of radionuclides which have unique half-life and functions, especially long-life elemental nuclide. This project explored the in-situ labeling methods of organic melanin nanoparticles with a promising diagnostic radionuclides named Iodine-124 (I-124), and using this novel multifunctional organic nanoparticles for preliminary molecular imaging studies. Generally, ultrafine particle size melanin nanoparticles (5.5 nm in diameter) were prepared by ultrasonication method using naturally occurring melanin, then PEG(3500) which had amino group at both ends was used as a stabilizer agent to obtain PEG-MNP nanocarriers (7.5 nm in diameter) with better water solubility and stability. The nanoparticles were full characterized by dynamic light scattering (DLS), transmission electron microscope (TEM) and H-1 NMR, respectively. Then, one kind of elemental nuclide was labeled. Classic iodine labeled method with N-Bromo Succinimide (NBS) was used as oxidant to oxidize active dihydroxyindole/indolequinone ring of PEG-MNP for electrophilic substitution reaction labeling I-124 (100.8 h). This reaction rate is extremely fast (60 s reaction time) and high labelling yield (>99%). The I-124 was labeled successfully and in-situ labeled PEG-MNP nanocarriers were obtained. After that, I-124 and I-124-PEG-MNP were used to further preclinical evaluation by micro-PET imaging. Micro-PET images were collected at 2 h, 24 h and 48 h after intravenous injection 7.4 MBq I-124 and I-124-PEG-MNP in normal Kunming mice (n=3). The ROI target area of heart, liver and thyroid were delineated for semi-quantitative analysis. Then, in order to verify the imaging ability of I-124-PEG-MNP in solid tumor. We built human pancreatic cancer BxPC3 xenograft model (n=3), and Micro-PET scans were performed at different time points. Results showed that the labeling rate of I-124 on PEG-MNP was 99.9%. And the radiochemical purity in vitro stability of I-124-PEG-MNP in 96 h was more than 90%. Micro-PET images showed that I-124-PEG-MNP had no obvious thyroid uptake which indicated no de-marking in mice. The radio-distribution of I-124 and I-124-PEG-MNP was substantially different in liver and thyroid (P<0.001). In vivo semi-quantitative analysis showed that the radio uptakes of organs were consistent with the distribution of nanoparticles. And the PET imaging of xenograft mice showed that I-124-PEG-MNP can utilize the enhanced permeability and retention effect (EPR) to be significantly enriched at the tumor and retained in the tumor site for more than 48 h. PEG-MNP has the ability to label long half-life nuclide I-124. This research provides an experimental basis for further construction of long-circulation multimodal imaging probes.

Radiolabeling Ovalbumin with 131I and 131I-OVA-PLGA/DDAB Nanoparticles to Vivo SPECT Imaging

Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA

Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine

Preparation and Preliminary Molecular Imaging Study of 124I In-Situ Labeled Organic Melanin Nanoparticles

Preparation and Micropet Imaging of Somatostatin Receptor Antagonist 68 Ga-NOTA-JR11

Direct radio-labeling of 99Tcm-IgG and its biologic distribution study

Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study

SPECT Imaging of Neuropilin Receptor Type-1 Expression with 131I-Labeled Monoclonal Antibody.

In Vivo Stability of Protein Coatings on Poly Lactic Co Glycolic Nanoparticles

Preparation and Biodistribution of ~(99M)tc-Pdgfr-β AODN

Study on Biodistribution and Imaging of Radioiodinated Antisense Oligonucleotides in Nude Mice Bearing Human Lymphoma

Visualisation of Dual Radiolabelled Poly(lactide-Co-glycolide) Nanoparticle Degradation in Vivo Using Energy-Discriminant SPECT.

Synthesis and Evaluation Of111in-Dota-mab109 Monoclonal Antibody for Potential SPECT Molecular Imaging

Preparation of OVA‐loaded γ‐PGA/CS nanocomposite delivery vector and its immune response

In vivo spatiotemporal characterizing diverse body transportation of optical labeled high immunity aluminium adjuvants with photoacoustic tomography

Dose escalation biodistribution, positron emission tomography/computed tomography imaging and dosimetry of a highly specific radionuclide-labeled non-blocking nanobody

RBC-hitchhiking PLGA nanoparticles loading β-glucan as a delivery system to enhance in vitro and in vivo immune responses in mice

Labeling of Octreotide with 131I and Its Vitro Uptake in Inflammatory Cells for Graves' Ophthalmopathy

Quaternized Cationic Carbon Dots as Antigen Delivery Systems for Improving Humoral and Cellular Immune Responses

Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant

Synthesis and evaluation of 111 In-labeled d -glucose as a potential SPECT imaging agent